Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
Main Authors: | Gil Cunha De Santis, Alfredo Mendrone, Dante Langhi, Jr., Dimas Tadeu Covas, Antônio Fabron, Jr., Afonso José Pereira Cortez, Carla Luana Dinardo, Eugênia Maria Amorim Ubiali, José Francisco Comenalli Marques, Jr., José Orlando Bordin, Marilia Alvares Rugani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137921000389 |
Similar Items
-
Is there justification for universal leukoreduction?
by: Alfredo Mendrone Jr., et al.
Published: (2014-07-01) -
COVID-19 convalescent plasma transfusion
by: Dante Mário Langhi, Junior, et al.
Published: (2020-04-01) -
Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016
by: Dante Langhi Jr, et al. -
Compassionate use of cell products
by: Gil Cunha de Santis, et al.
Published: (2013-01-01) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process
by: Gil Cunha De Santis, et al.
Published: (2021-11-01)